MARKET

ASND

ASND

Ascendis Pharma
NASDAQ
136.93
-6.25
-4.37%
After Hours: 136.93 0 0.00% 16:00 04/25 EDT
OPEN
140.59
PREV CLOSE
143.18
HIGH
140.84
LOW
136.19
VOLUME
366.62K
TURNOVER
0
52 WEEK HIGH
161.00
52 WEEK LOW
66.03
MARKET CAP
7.90B
P/E (TTM)
-14.5047
1D
5D
1M
3M
1Y
5Y
Ascendis Pharma to Report First Quarter 2024 Financial Results and Provide Business Update on May 2, 2024
Ascendis Pharma A/S will report first quarter 2024 financial results and provide a business update on Thursday, May 2, 2024. The company will also host a conference call and live webcast to discuss its financial results. Ascendis Pharma will report its results after the close of the U.S. Financial markets.
Barchart · 5h ago
Ascendis Pharma Gains UK Authorization for YORVIPATH
TipRanks · 1d ago
Ascendis Pharma Says UK Approves YORVIPATH For Treatment Of Adults With Chronic Hypoparathyroidism
NASDAQ · 1d ago
Why Earnings Season Could Be Great for Ascendis Pharma (ASND)
NASDAQ · 1d ago
Ascendis Pharma Is Maintained at Equal-Weight by Morgan Stanley
Dow Jones · 3d ago
Morgan Stanley Maintains Equal-Weight on Ascendis Pharma, Maintains $116 Price Target
Benzinga · 3d ago
Weekly Report: what happened at ASND last week (0415-0419)?
Weekly Report · 3d ago
$1000 Invested In Ascendis Pharma 15 Years Ago Would Be Worth This Much Today
Ascendis Pharma has outperformed the market over the past 15 years by 17.87%. The company has an average annual return of 30.26%. If an investor bought $1000 of ASND stock 15 years ago, it would be worth $50,829.75 today.
Benzinga · 04/18 19:30
More
About ASND
Ascendis Pharma A/S is a Denmark-based company that manufactures pharmaceutical products. The Company produces products for the treatments of growth hormone deficiency, endocrinology, central nervous system disorders, infectious diseases, and diabetes. The Company operates globally though its subsidiaries: Ascendis Pharma GmbH (Germany), Ascendis Pharma, Inc. (Delaware, United States), Ascendis Pharma Endocrinology, Inc. (Delaware, United States), Ascendis Pharma, Ophthalmology Division A/S (Denmark), Ascendis Pharma, Endocrinology Division A/S (Denmark), Ascendis Pharma Bone Diseases A/S (Denmark), Ascendis Pharma Growth Disorders A/S (Denmark) and Ascendis Pharma Oncology Division A/S (Denmark).

Webull offers Ascendis Pharma A/S (ADR) stock information, including NASDAQ: ASND real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASND stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASND stock methods without spending real money on the virtual paper trading platform.